A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors

NCT05649761 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: QL1604 injection

Sponsor

Qilu Pharmaceutical Co., Ltd.